Piek, Arnold
Smit, Leonie
Suthahar, Navin
Bakker, Stephan J. L.
de Boer, Rudolf A.
Silljé, Herman H. W.
Funding for this research was provided by:
Netherlands Heart Foundation (CVON Predict2, grant no. 2018-30, CVON Predict2, grant no. 2018-30)
the Foundation Leducq (CurePLaN, CurePLaN)
Article History
Received: 23 November 2020
Accepted: 5 April 2021
First Online: 21 April 2021
Competing interests
: The University Medical Centre Groningen, which is the affiliation of all authors, has received research grants and/or fees from AstraZeneca, Abbott, Bristol‐Myers Squibb, Novartis, Novo Nordisk and Roche. R.A.dB. has received personal fees from Abbott, AstraZeneca, Novartis and Roche. The other authors have nothing to disclose.